“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When ...
Generation Bio announces new programs using ctLNP for targeted siRNA delivery in T cell-driven autoimmune diseases, aiming for IND submission in 2026. Development of novel siRNA therapeutics using ...
Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes discontinuing a clinical-stage allogeneic cell therapy. The layoffs are expected to be ...
Cell biology is a branch of biological sciences that investigates the structure, function, dynamics, and regulation of cells as the fundamental units of life. It encompasses the study of cellular ...
University of Chicago fourth-year student Prithi Srinivasan has been named a 2026 Gates Cambridge Scholar and will pursue a ...
Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...
Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...
When Francisco Leon talks about the medical science behind the biotech company he founded in 2023, it sounds like something out of a movie. The company, Tolerance Bio, focuses on preserving the body’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results